SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014Pharmacokinetics of levofloxacin in M(X)DR tuberculosis patients - N. Van’t Boveneind- VrubleuskayaView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014A semi mechanistic pharmacokinetic-pharmacodynamic template model for studying antitubercular drug effects in vitro - O. CleweView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014A quantitative and systems pharmacology approach to dose optimization in experimental tuberculosis: opportunities and experimental data needs - M. LyonsView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014The inhibitory potential of TB drugs on ATP-binding cassette transporters MRP1- 5, P-gp, BCRP and BSEP - L. Te BrakeView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014High dose rifampicin: a phase II trial comparing 10, 15 and 20 mg/kg rifampicin for two months - R. AarnoutseView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014Population pharmacokinetics and bacterial dynamics of sutezolid in patients with active tuberculosis - K.B. LarsonView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014Drug-drug interactions between bedaquiline and the antiretrovirals nevirapine and lopinavir/ritonavir in patients - M. PandieView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014The Critical Path to TB Drug Regimens: Advancing through a Multidisciplinary, Multipartner Approach - Klaus Romero, MD, MSView Slideset
SNSharon NachmanMDSlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014Clinical Pharmacology Issues for Pediatric TB - Sharon Nachman, MDView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014Pharmacokinetics of rifampin among pregnant women with tuberculosis and HIV co-infection - K. DooleyView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014A simultaneous population pharmacokinetic analysis in Malawian adults and children of rifampicin - A. SchipaniView Slideset
SNSharon NachmanMDSlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014Pharmacokinetics of rifampicin, isoniazid and pyrazinamide in children on 2010 WHO/IUATLD guideline doses - H. McIlleronView Slideset
